Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer Disease

NCT01453569 is registered in ClinicalTrials.gov with Shanghai Greenvalley Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01453569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01453569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer Disease
Lead sponsor
Shanghai Greenvalley Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2011
Completion date
August 31, 2013
Enrollment
255 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive impairment